The recording will be available soon.
Join us for an inspiring online event from February 3 to 7, 2025, as we share groundbreaking research presented at major conferences in 2024. Over five days, with up to two hours of presentations each day, seize this opportunity to dive deep into topics related to clinical research on CyberKnife®, TomoTherapy®, and Radixact® Systems. Choose the indications that inspire you, or immerse yourself in the journey each day!
Each session is pending approval from CAMPEP for 1.5 MPCEC hours and approved by ASRT for 2.25 Category A credits.
- Mon, Feb 3rd
- Tues, Feb 4th
- Wed, Feb 5th
- Thurs, Feb 6th
- Fri, Feb 7th
Monday February 3rd, 2025: CNS Indications
16:10 PM
Safety and efficacy of CyberKnife radiosurgery plus anlotinib hydrochloride in patients with recurrent glioblastoma: a prospective phase II single-arm study (HSCK-002)
16:20 PM
Helical TomoTherapy Compared to Intensity-Modulated Radiation Therapy in Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients with Limited-Stage Small-Cell Lung Cancer
Presenter: Hui Zhu (Shandong Cancer Hospital and Institute, China)
16:30 PM
Stereotactic Radiosurgery and Radiotherapy for Brainstem Metastases: An International Multicenter Analysis
16:40 PM
Tumor Control Probability and Time-Dose Response Modeling for Stereotactic Radiosurgery of Uveal Melanoma
16:50 PM
Neurocognition and Quality of Life for Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection
Presenter: Rami El Shafie (University Medical Center Gottingen, Germany)
17:00 PM
Reappraising prognostic factors after SRS/FSRT of brain metastases in the era of targeted therapies
Presenter: Christoph A Grott (Heidelberg, Germany)
17:10 PM
Hypofractionated radiosurgery for residual/ recurrent non secreting pituitary adenomas an exploratory study: preliminary results
Tuesday, February 4th, 2025: CNS Indications
16:00 PM
Accuray Exchange President welcome and chair introduction
Presenter: Sean Collins (Tampa General Hospital, USA)
Presenter: Pantaleo Romanelli (Renaissance Institute of Precision Oncology & Radiosurgery, USA)
16:10 PM
Stereotactic diffusion tensor imaging tractography for brain AVM located in the in deep seated eloquent areas during radiosurgery treatment planning
Presenter: Enmin Wang (Huashan, China)
16:20 PM
A proof of concept for MR-only workflow in CyberKnife intracranial radiosurgery
Presenter: Evaggelos Pantelis (National and Kapodistrian University of Athens, Greece)
16:30 PM
Stereotactic radiosurgery in choroidal hemangioma with CyberKnife
Presenter: Kaan Oysul (Ankara, Turkey)
16:40 PM
Simultaneous Multiple Brain Metastases SRS/SRT: An Evaluation of Dose Coverage Uncertainty Induced By Intra-Fraction Patient Motion during Beam Delivery
Presenter: Xiaoming Chen (Fox Chase, USA)
16:50 PM
Multicenter approach to guide plan optimization of robotic intracranial SRS/SRT
Presenter: Sara Broggi (San Raffaele, Italy)
17:00 PM
Retreatment for Resistant or Recurrent Pain in Trigeminal Neuralgia Using Frameless LINAC Radiosurgery
Presenter: Pantaleo Romanelli (Milan, Italy)
17:10 PM
Clinical outcome and dosimetric feasibility of hippocampal sparing whole brain radiotherapy
Presenter: Bhuvana J. (Ahmedabad, India)
Wednesday, February 5th, 2025: Breast and Gynecological Cancers
16:00 PM
Chief Medical Officer welcome and chair introduction
Presenter: Seth Blacksburg (Accuray)
Presenter: Barbara Jereczek-Fossa (University of Milan & European Institute of Oncology, Italy)
16:20 PM
Research on Thread Effect in HT Radiotherapy for Cervical Cancer
Presenter: Li Guang (Chongqing University Cancer Hospital, China)
16:10 PM
Outcomes of pelvic reirradiation with stereotactic radiotherapy for gynaecological cancer recurrence
Presenter: Susan Lalondrelle (The Royal Marsden NHS Foundation Trust, UK)
16:30 PM
CYBERNEO trial: Update of results at 14 years of follow-up
16:40 PM
Moderate hypofractionation with simultaneous integrated boost after conservative surgery for Bca
Presenter: Roberta Tummineri (San Raffaele, Italy)
16:50 PM
Stereotactic Partial Breast Irradiation: 4-year Clinical Results and Cosmetic Outcomes
Presenter: Norbert Meszaros (National Institute of Oncology, Hungary)
17:00 PM
Surface guided ring gantry radiotherapy in deep inspiration breath hold for breast cancer patients
Presenter: Mustafa Kadhim (Skåne University Hospital, Sweden)
17:10 PM
Left breast cancer dosimetry with Accuray VOLO Ultra optimizer: a comparison with DIBH
Presenter: Patrizia Urso (Gruppo Ospedaliero Moncucco, Italy)
17:20 PM
Preoperative single-fraction RT for early stage BC: preliminary results from CRYSTAL phase I/II study
Presenter: Maria Zerella (IEO, Italy)
Thursday, February 6th, 2025: Thorax and Rare Indications
16:00 PM
Accuray Exchange Executive Board welcome and chair introduction
Presenter: Jun Yang, Ph.D.., JunXin Oncology Group, Foshan, Guangdong, China
16:05 PM
Chair welcome
Presenter: Umberto Ricardi, University of Turin, Italy
16:10 PM
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy Via Helical TomoTherapy Versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable Stage III Non-small Cell Lung Cancer: A Multicenter, Randomized Phase III Trial
Presenter: XiaoHong Xu (Zhongshan Hospital, China)
16:20 PM
Optimization of Treatment Plan Parameters Used in Helical TomoTherapy for Small Cell Lung Cancer Patients with Extensive Pleural Metastasis
Presenter: Longyan Duan (Shanghai, China)
16:30 PM
Radiation-Related Late Toxicities Following Total Marrow Irradiation Transplant Conditioning Regimens
Presenter: Colton Ladbury (City of Hope, USA)
16:40 PM
Clinical outcomes following stereotactic ablative body radiotherapy to central lung tumours
Presenter: Julie Duong (Mount Vernon Cancer Centre, UK)
16:50 PM
Modern radiotherapy for extended cutaneous lesions from lymphomas: results from a multicenter study
Presenter: Mario Levis (University of Torino, Italy)
17:00 PM
Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
Presenter: Jeffrey Wong (City of Hope, USA)
Friday, February 7th, 2025: Genitourinary and Gastrointestinal Cancers
16:00 PM
Presenter: Seth Blacksburg (Accuray)
16:05 PM
Presenter: Alison Tree (The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK)
16:10 PM
Presenter: Nick van As (The Royal Marsden NHS Foundation Trust, UK)
16:20 PM
The UPRATE trial: feasibility of seminal vesicle PTV-margin reduction with online adaptive SBRT
Presenter: Victor Brand (Erasmus, Netherlands)
16:30 PM
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Presenter: Binnaz Yasar (The Royal Marsden NHS Foundation Trust, UK)
16:40 PM
Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Presenter: Nima Aghdam (Beth Israel, USA)
16:50 PM
Outcomes of a phase II trial of high-dose online-adaptive SBRT for abdominal oligometastases
Presenter: Lucy A. van Werkhoven (Erasmus, Netherlands)
17:00 PM
SBRT and systemic therapy for patients with Oligometastatic Renal Cell Carcinoma
Presenter: Miriam Torrisi (Ospedale San Raffaele, Italy)
17:10 PM
SABR for Liver De Novo, Repeat, and Induced Oligometastatic Disease
Presenter: Miriam Torrisi (Ospedale San Raffaele, Italy)
17:20 PM
Acute toxicity from PACE-C comparing Stereotactic Body Radiotherapy (SBRT) with moderate hypofractionation (MHRT)
Presenter: Alison Tree (The Royal Marsden NHS Foundation Trust, UK)